In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Extra participants might be enrolled in the recognized monotherapy dosign routine. In Section B, contributors will receive oral ruxolitinib and ABBV-744 will likely be specified as "add-on" therapy. In Section C, https://alexanderg544rcn6.bloggerchest.com/profile